Net profit of Sudarshan Pharma Industries reported to Rs 3.96 crore in the quarter ended June 2025 as against net loss of Rs 1.21 crore during the previous quarter ended June 2024. Sales rose 46.43% to Rs 145.26 crore in the quarter ended June 2025 as against Rs 99.20 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
| Sales | 145.26 | 99.20 | 46 |
| OPM % | 7.60 | 2.10 | - |
| PBDT | 6.29 | -0.88 | LP |
| PBT | 5.41 | -1.55 | LP |
| NP | 3.96 | -1.21 | LP |